Fernando Guedes1, Gabriel Elias Sanches2, Rosana Siqueira Brown2, Rodrigo Salvador Vivas Cardoso2, Ana Caroline Siquara-de-Sousa3, Agostinho Ascenção4, Antônio Carlos Iglesias4. 1. Department of Surgery, Division of Neurosurgery, Gaffrée e Guinle University Hospital, School of Medicine, Federal University of Rio de Janeiro State (UNIRIO), 775 Mariz e Barros Street, Rio de Janeiro, RJ, 20270-901, Brazil. neuroguedes@yahoo.com.br. 2. Department of Surgery, Division of Neurosurgery, Gaffrée e Guinle University Hospital, School of Medicine, Federal University of Rio de Janeiro State (UNIRIO), 775 Mariz e Barros Street, Rio de Janeiro, RJ, 20270-901, Brazil. 3. Department of Pathology, Antônio Pedro University Hospital, Fluminense Federal University (UFF), Niterói, RJ, Brazil. 4. Department of Surgery, Gaffrée e Guinle University Hospital, School of Medicine, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, RJ, Brazil.
Abstract
OBJECTIVE: Data concerning the surgical treatment of lumbosacral plexus tumors (LSPTs) is scarce. This study aims to present our experience with a series of 19 patients surgically treated for symptomatic LSPTs at our institution. METHODS: This is a retrospective study of 19 patients surgically treated for symptomatic LSPTs from 2011 to 2019. Clinical data were retrieved from medical records and consisted of age, gender, clinical presentation, location of the lesion, surgical approach, final histopathologic diagnosis, follow-up time, outcomes, and complications. RESULTS: Nineteen surgical procedures were conducted. Thirteen patients were female and six, male. The median age of patients was 45 years (range 20 to 63 years). No patients harbored genetic syndromes. Surgical treatment appears to be correlated to the reduction of pain in patients with peripheral nerve sheath tumors (PNSTs), as assessed by visual analog scale (VAS). Sixteen patients did not present with new-onset deficits during follow-up (84.2%), two of whom recovered from their preoperative deficit. Four patients presented with postoperative weakness. The histopathological diagnoses were 11 schwannomas, four neurofibromas, three metastases, and one lymphoma. CONCLUSIONS: LSPTs are rare. When surgical treatment is indicated, it usually requires multidisciplinary management. Surgery appears to be effective concerning the reduction of pain in PNSTs and may also recover neurological deficits. Iatrogenic neurological deficits are an evident risk, such that intraoperative multimodal monitoring should always be performed if available. In lesions involving the sacral plexus, we found it to be indispensable.
OBJECTIVE: Data concerning the surgical treatment of lumbosacral plexus tumors (LSPTs) is scarce. This study aims to present our experience with a series of 19 patients surgically treated for symptomatic LSPTs at our institution. METHODS: This is a retrospective study of 19 patients surgically treated for symptomatic LSPTs from 2011 to 2019. Clinical data were retrieved from medical records and consisted of age, gender, clinical presentation, location of the lesion, surgical approach, final histopathologic diagnosis, follow-up time, outcomes, and complications. RESULTS: Nineteen surgical procedures were conducted. Thirteen patients were female and six, male. The median age of patients was 45 years (range 20 to 63 years). No patients harbored genetic syndromes. Surgical treatment appears to be correlated to the reduction of pain in patients with peripheral nerve sheath tumors (PNSTs), as assessed by visual analog scale (VAS). Sixteen patients did not present with new-onset deficits during follow-up (84.2%), two of whom recovered from their preoperative deficit. Four patients presented with postoperative weakness. The histopathological diagnoses were 11 schwannomas, four neurofibromas, three metastases, and one lymphoma. CONCLUSIONS: LSPTs are rare. When surgical treatment is indicated, it usually requires multidisciplinary management. Surgery appears to be effective concerning the reduction of pain in PNSTs and may also recover neurological deficits. Iatrogenic neurological deficits are an evident risk, such that intraoperative multimodal monitoring should always be performed if available. In lesions involving the sacral plexus, we found it to be indispensable.
Entities:
Keywords:
Lumbosacral plexus; Neurilemmoma; Neurofibroma; Peripheral nervous system neoplasms
Authors: Matteo Anghileri; Rosalba Miceli; Marco Fiore; Luigi Mariani; Andrea Ferrari; Chiara Mussi; Laura Lozza; Paola Collini; Patrizia Olmi; Paolo G Casali; Silvana Pilotti; Alessandro Gronchi Journal: Cancer Date: 2006-09-01 Impact factor: 6.860
Authors: Daipayan Guha; Benjamin Davidson; Mustafa Nadi; Naif M Alotaibi; Michael G Fehlings; Fred Gentili; Taufik A Valiante; Charles H Tator; Michael Tymianski; Abhijit Guha; Gelareh Zadeh Journal: J Neurosurg Date: 2017-07-07 Impact factor: 5.115
Authors: Joseph Alderete; Eduardo N Novais; Eric J Dozois; Peter S Rose; Franklin F Sim Journal: Clin Orthop Relat Res Date: 2010-11 Impact factor: 4.176
Authors: Eric J Dozois; Jarrod C H Wall; Robert J Spinner; David J Jacofsky; Michael J Yaszemski; Franklin H Sim; Steven L Moran; Robert R Cima; Dirk R Larson; Michael G Haddock; Scott H Okuno; David W Larson Journal: Ann Surg Oncol Date: 2009-02-05 Impact factor: 5.344